Home > Resources > Company Profiles > Applied Biosystems, Incorporated

Applied Biosystems, Incorporated (ABI)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Enter the text you see in the image *

Letters are not case-sensitive, disregard spaces.

Try a New One

This helps us prevent automated registrations and spamming.

Email Confirmation

Tony L. White , CEO/Chairman of the Board/President/Director

www.appliedbiosystems.com

Industry: Technology

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

Conducts business through three business segments: Applied Biosystems Group, serves the life science industry; Celera Genomics Group, engaged in the discovery of targeted therapeutics; and Celera Diagnostics, focuses on diagnostic products.

News Feeds

Invitrogen 2Q profit rises on sales boost AP
Jul 24 2008
Applied Biosystems profit falls, but tops forecast AP
Jul 24 2008
Applied Biosystems reports $86.4M Q4 profit East Bay
Jul 24 2008
Wall Street expects more M&A in life sciences AP
Jul 01 2008
Applera adopts Applied Biosystems name East Bay
Jul 01 2008
Applera adopts Applied Biosystems name San Jose
Jul 01 2008

Press Releases

Applied Biosystems Reports Financial Results for Fourth Quarter and Fiscal 2008 Jul-24-2008, 07:00AM EDT
Applied Biosystems Adds New Members to Software Development Community to Advance Genomic Analysis Research Jul-22-2008, 07:30AM EDT
Applied Biosystems Enhances Software Development Community by Adding Application Specific Tools for Genomic Analysis Research Jul-21-2008, 07:30AM EDT
Scientists Report Most Comprehensive View of Mammalian Transcriptome Jul-16-2008, 07:30AM EDT
Heart Disease Specialists Meet Spanish Footballers to Develop Tools for Detecting Sudden Death Syndrome Jul-15-2008, 07:30AM EDT

News From Around the Web

News

Invitrogen 2Q profit rises on sales boost (MSN Money)

Jul 24 2008
Applied Biosystems' fiscal 4th - quarter profit falls slightly, but tops Wall Street forecast (Canadian Business Online)

Jul 24 2008
Illumina Polishes Its Biochips (Motley Fool)

Jul 24 2008
Applied Biosystems quarterly profit hits 50 cents a share (MarketWatch)

Jul 24 2008
Applied Biosystems Adds New Members to Software Development Community to … (TMCnet.com)

Jul 22 2008
A Guide to the Emerging Global Market in Next Generation Sequencing for Life Science R&D: Advancing to the $1,000 Genome (PharmaLive)

Jul 21 2008
Applied Biosystems Enhances Software Development Community by Adding Application Specific Tools for Genomic Analysis Research (PharmaLive)

Jul 21 2008
Research and Markets: A Guide to the Emerging Global Market Generation Sequencing fo… (TMCnet.com)

Jul 21 2008
Univ. of Queensland and Applied Biosystems Profile Mouse Transcriptome (Genetic Engineering News)

Jul 17 2008

Employees

Number of Employees: 5,000

Revenue per Employee: $430,072

Financials

Quarterly

Annual

Income Statement	04/2008	01/2008	11/2007	07/2007
Sales	250.97 Mil.	237.8 Mil.	205.31 Mil.	231.18 Mil.
Gross Operating Profit	350.39 Mil.	324.1 Mil.	295.93 Mil.	326.06 Mil.
Operating Income before D & A (EBITDA)	120.68 Mil.	124.6 Mil.	96.95 Mil.	-1.85 Mil.
Total Income Before Interest Expenses (EBIT)	136.07 Mil.	128.7 Mil.	90.66 Mil.	103.51 Mil.
Total Net Income	86.6 Mil.	86.3 Mil.	60.94 Mil.	87.81 Mil.
Basic EPS, Total	0.5	0.5	0.33	0.48
Diluted EPS, Total	0.49	0.49	0.32	0.46

BALANCE STATEMENT	04/2008	01/2008	11/2007	07/2007
Cash and Equivalents	403.57 Mil.	NA	277.18 Mil.	293.17 Mil.
Total Assets	1.49 Bil.	NA	984.06 Mil.	1.23 Bil.
Total Liabilities	801.02 Mil.	NA	790.13 Mil.	587.72 Mil.
Total Capitalization	2.24 Bil.	NA	1.08 Bil.	1.59 Bil.

Cash Flow	04/2008	01/2008	11/2007	07/2007
Net Cash From Continuing Operations	225.97 Mil.	NA	97.13 Mil.	366.14 Mil.
Net Cash From Investing Activities	184.37 Mil.	NA	191.6 Mil.	-382.98 Mil.
Net Cash From Financing Activities	-351.5 Mil.	NA	-314.9 Mil.	-80.1 Mil.
Net Change in Cash & Cash Equivalents	62.7 Mil.	NA	-15.99 Mil.	-80.75 Mil.

Income Statement	2007	2006	2005	2004
Sales	867.86 Mil.	794.11 Mil.	752.56 Mil.	738.59 Mil.
Gross Operating Profit	1.23 Bil.	1.12 Bil.	1.03 Bil.	1 Bil.
Operating Income before D & A (EBITDA)	428.71 Mil.	388.43 Mil.	324.9 Mil.	329.71 Mil.
Total Income Before Interest Expenses (EBIT)	258.98 Mil.	317.23 Mil.	297.2 Mil.	239.74 Mil.
Total Net Income	179.4 Mil.	275.12 Mil.	236.89 Mil.	182.88 Mil.
Basic EPS, Total	0.98	1.47	1.21	0.84
Diluted EPS, Total	0.94	1.43	1.19	0.83

BALANCE STATEMENT	2007	2006	2005	2004
Cash and Equivalents	293.17 Mil.	373.92 Mil.	756.24 Mil.	504.95 Mil.
Total Assets	1.23 Bil.	1.01 Bil.	1.39 Bil.	1.11 Bil.
Total Liabilities	587.72 Mil.	573.19 Mil.	546.69 Mil.	517.69 Mil.
Total Capitalization	1.59 Bil.	1.48 Bil.	1.52 Bil.	1.24 Bil.

Cash Flow	2007	2006	2005	2004
Net Cash From Continuing Operations	366.14 Mil.	375.28 Mil.	334.27 Mil.	289.26 Mil.
Net Cash From Investing Activities	-382.98 Mil.	-295.09 Mil.	-33.83 Mil.	-35.64 Mil.
Net Cash From Financing Activities	-80.1 Mil.	-459.39 Mil.	8 Mil.	-345.46 Mil.
Net Change in Cash & Cash Equivalents	-80.75 Mil.	-382.32 Mil.	299.91 Mil.	-96.72 Mil.

Applied Biosystems, Incorporated (ABI)

Company Information

Overview

Employees

Financials

Company Profile Change Request